Cathy I Cheng, MD
Internal Medicine · Anaheim
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 4
Offices
4 locations · Southern California Permanente Medical Group · Stanford Health Care
Looking this up.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Cheng’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A124102 · Current
Licensed to practise in California · since 2013 · expires 2027-01-31 · University of Pittsburgh School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 76.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Original Medicare doctor bills
$72,384
Medicare paid this office $72,384 for 303 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Long return visit (40+ min) | 171 | $33,698 | $143 |
| New patient visit (60+ min) | 85 | $12,878 | $152 |
| Return visit (30+ min) | 101 | $11,717 | $101 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 214 | $4,055 | $14 |
| Sleep study in sleep lab (6 years or older) | 47 | $3,875 | $81 |
See all 7 services
| Long return visit (40+ min) | 171 | $33,698 | $143 |
| New patient visit (60+ min) | 85 | $12,878 | $152 |
| Return visit (30+ min) | 101 | $11,717 | $101 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 214 | $4,055 | $14 |
| Sleep study in sleep lab (6 years or older) | 47 | $3,875 | $81 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 32 | $3,601 | $92 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 28 | $1,126 | $27 |
Who their Medicare patients are
303 Original Medicare patients in 2024. Average age 75 · Women 43% · Health risk score 1.07. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 75% · Coronary heart disease 35% · Diabetes 30% · Atrial fibrillation 25% · Depression 21% · Chronic kidney disease 19% · Cancer 19% · Heart failure 10% · COPD 9% · Stroke 9% · Dementia 7%.
The office billed $176,462, Medicare allowed $100,854 and paid $72,384; for 888 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 303 | 888 | 75 | 1.07 | $176,462 | $72,384 |
| 2023 | 321 | 833 | 75 | 1.09 | $236,609 | $100,099 |
| 2022 | 178 | 280 | 72 | 1.10 | $68,877 | $25,082 |
| 2021 | 194 | 363 | 70 | 0.99 | $105,334 | $41,347 |
| 2020 | 128 | 208 | 69 | 1.09 | $55,197 | $17,891 |
| 2019 | 102 | 175 | 71 | 1.03 | $44,389 | $18,804 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 8 services
| New patient visit (60+ min) | 249 | $44,724 | $180 |
| Long return visit (40+ min) | 120 | $23,688 | $154 |
| Sleep study in sleep lab (6 years or older) | 89 | $9,182 | $99 |
| Return visit (30+ min) | 69 | $8,577 | $107 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 55 | $6,352 | $102 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 104 | $3,937 | $27 |
| New patient visit (45+ min) | 12 | $1,503 | $125 |
| Sleep study including heart rate, breathing, airflow, and effort | 19 | $662 | $35 |
2022: 8 services
| New patient visit (60+ min) | 67 | $10,048 | $150 |
| Return visit (30+ min) | 52 | $3,787 | $73 |
| Long return visit (40+ min) | 30 | $3,734 | $124 |
| Short return visit (20+ min) | 36 | $1,958 | $52 |
| Sleep study in sleep lab (6 years or older) | 20 | $1,795 | $90 |
| New patient visit (45+ min) | 13 | $1,198 | $92 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 15 | $1,087 | $28 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 12 | $972 | $81 |
2021: 6 services
| New patient visit (60+ min) | 116 | $18,358 | $158 |
| Long return visit (40+ min) | 47 | $7,009 | $127 |
| Return visit (30+ min) | 54 | $6,252 | $99 |
| Sleep study in sleep lab (6 years or older) | 37 | $3,329 | $90 |
| Short return visit (20+ min) | 44 | $3,210 | $64 |
| Sleep study in sleep lab with continuous airway pressure (6 years or older) | 14 | $1,398 | $100 |
2020: 5 services
| New patient visit (60+ min) | 39 | $5,149 | $132 |
| Return visit (30+ min) | 54 | $3,756 | $64 |
| Long return visit (40+ min) | 21 | $2,918 | $108 |
| New patient visit (45+ min) | 23 | $1,932 | $84 |
| Short return visit (20+ min) | 17 | $881 | $52 |
2019: 4 services
| New patient visit (45+ min) | 57 | $6,961 | $122 |
| Return visit (30+ min) | 41 | $4,648 | $83 |
| New patient visit (60+ min) | 27 | $4,244 | $157 |
| Long return visit (40+ min) | 21 | $2,317 | $101 |
Drugs they prescribed that Part D paid
$3,744
Pharmacies billed $3,744 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 81) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
72 generic and fewer than 11 brand-name prescriptions · $3,744 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Gabapentin | 13 | $215 | $17 |
| Zolpidem | 27 | $58 | $2 |
Year by year
| 2024 | 81 | 30 | 0% (0) | None | $3,744 |
| 2023 | 75 | 37 | 0% (0) | None | $2,916 |
| 2022 | 104 | 38 | 13% (13) | None | $3,548 |
| 2021 | 135 | 60 | 19% (25) | 10% | $4,877 |
| 2020 | 88 | 35 | None | None | $1,319 |
| 2019 | 76 | 37 | None | None | $1,108 |
| 2018 | 65 | 30 | None | 17% | $1,104 |
| 2017 | 374 | 118 | None | 22% | $14,311 |
| 2016 | 691 | 180 | 3% (18) | None | $40,415 |
| 2015 | 517 | 177 | 6% (29) | None | $43,296 |
| 2014 | 638 | 93 | 8% (48) | 24% | $41,227 |
| 2013 | 645 | 95 | 16% (104) | 20% | $51,211 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Gabapentin | 20 | $207 | $10 |
| Zolpidem | 18 | $44 | $2 |
2022: 3 drugs
| Pramipexole Dihydrochloride | 12 | $378 | $32 |
| Gabapentin | 11 | $270 | $25 |
| Trazodone | 21 | $251 | $12 |
2021: 4 drugs
| Oxycontin | 12 | $2,755 | $230 |
| Gabapentin | 17 | $604 | $36 |
| Trazodone | 26 | $291 | $11 |
| Zolpidem | 22 | $76 | $3 |
2020: 2 drugs
| Trazodone | 21 | $187 | $9 |
| Zolpidem | 11 | $29 | $3 |
2019: 2 drugs
| Trazodone | 13 | $120 | $9 |
| Zolpidem | 13 | $72 | $6 |
2017: 8 drugs
| Atorvastatin | 30 | $689 | $23 |
| Warfarin | 34 | $426 | $13 |
| Pantoprazole | 25 | $386 | $15 |
| Furosemide | 28 | $313 | $11 |
| Lisinopril | 21 | $203 | $10 |
| Metoprolol | 22 | $175 | $8 |
| Atenolol | 12 | $144 | $12 |
| Amlodipine Besylate | 11 | $71 | $6 |
2016: 13 drugs
| Atorvastatin | 55 | $1,291 | $23 |
| Clopidogrel | 30 | $651 | $22 |
| Pantoprazole | 35 | $648 | $19 |
| Levetiracetam | 19 | $613 | $32 |
| Hydralazine | 13 | $525 | $40 |
| Warfarin | 40 | $514 | $13 |
| Furosemide | 44 | $476 | $11 |
| Metoprolol | 52 | $401 | $8 |
| Losartan | 14 | $236 | $17 |
| Prednisone | 12 | $184 | $15 |
| Lisinopril | 21 | $181 | $9 |
| Carvedilol | 16 | $141 | $9 |
| Ciprofloxacin | 15 | $130 | $9 |
2015: 11 drugs
| Humulin N | 16 | $1,264 | $79 |
| Hydrocodone-Acetaminophen | 14 | $670 | $48 |
| Atorvastatin | 27 | $557 | $21 |
| Pantoprazole | 22 | $423 | $19 |
| Warfarin | 27 | $404 | $15 |
| Clopidogrel | 12 | $382 | $32 |
| Metoprolol | 38 | $294 | $8 |
| Prednisone | 18 | $280 | $16 |
| Furosemide | 23 | $276 | $12 |
| Ciprofloxacin | 13 | $151 | $12 |
| Lisinopril | 12 | $111 | $9 |
2014: 16 drugs
| Venlafaxine Hcl Er | 13 | $2,474 | $190 |
| Vesicare | 11 | $2,439 | $222 |
| Tamsulosin | 13 | $804 | $62 |
| Atorvastatin | 38 | $782 | $21 |
| Hydrocodone-Acetaminophen | 26 | $521 | $20 |
| Finasteride | 26 | $468 | $18 |
| Lactulose | 11 | $312 | $28 |
| Levothyroxine | 34 | $296 | $9 |
| Metformin | 16 | $262 | $16 |
| Omeprazole | 15 | $174 | $12 |
| Citalopram Hbr | 17 | $154 | $9 |
| Amlodipine Besylate | 21 | $126 | $6 |
| Metoprolol | 14 | $115 | $8 |
| Lisinopril | 20 | $115 | $6 |
| Pantoprazole | 11 | $101 | $9 |
| Hydrochlorothiazide | 22 | $92 | $4 |
2013: 14 drugs
| Hydrocodone-Acetaminophen | 52 | $1,096 | $21 |
| Omeprazole | 18 | $734 | $41 |
| Morphine Sulfate Er | 14 | $660 | $47 |
| Atorvastatin | 21 | $652 | $31 |
| Levothyroxine | 35 | $296 | $8 |
| Finasteride | 14 | $258 | $18 |
| Gabapentin | 16 | $243 | $15 |
| Famotidine | 16 | $167 | $10 |
| Lisinopril | 23 | $130 | $6 |
| Tramadol | 11 | $125 | $11 |
| Metoprolol | 12 | $97 | $8 |
| Hydrochlorothiazide | 13 | $84 | $6 |
| Promethazine | 15 | $74 | $5 |
| Lorazepam | 14 | $55 | $4 |
Money from drug and device companies
$1,030 in 2025
| 2025 | 5 | 28 | $150 | $1,030 |
| 2024 | 5 | 30 | None | $834 |
| 2023 | 4 | 32 | None | $752 |
| 2022 | 3 | 3 | None | $58 |
| 2021 | 3 | 4 | None | $111 |
| 2020 | 2 | 2 | None | $37 |
| 2019 | 2 | 6 | None | $93 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Jazz Pharmaceuticals | Xywav | $438 | 17 payments
|
| Inspire Medical Systems | Inspire | $346 | 5 payments
|
| Avadel CNS Pharmaceuticals | Lumryz | $190 | 4 payments
|
| Lilly USA | Zepbound | $28 | 1 payment
|
| Fisher & Paykel Healthcare | Fisher & Paykel Healthcare | $27 | 1 payment
|
See all 28 published payments
| Inspire Medical Systems | Meals · 2025-11-26 | Inspire | $21 |
| Jazz Pharmaceuticals | Meals · 2025-11-06 | Xywav | $12 |
| Jazz Pharmaceuticals | Meals · 2025-11-06 | Xywav | $5 |
| Jazz Pharmaceuticals | Meals · 2025-10-03 | Xywav | $16 |
| Jazz Pharmaceuticals | Meals · 2025-10-02 | Xywav | $10 |
| Inspire Medical Systems | Meals · 2025-09-20 | Inspire | $157 |
| Jazz Pharmaceuticals | Meals · 2025-08-05 | Xywav | $3 |
| Jazz Pharmaceuticals | Meals · 2025-08-04 | Xywav | $7 |
| Jazz Pharmaceuticals | Meals · 2025-06-23 | Xywav | $37 |
| Lilly USA | Meals · 2025-04-03 | Zepbound | $28 |
| Jazz Pharmaceuticals | Meals · 2025-03-28 | Xywav | $8 |
| Jazz Pharmaceuticals | Meals · 2025-03-28 | Xywav | $7 |
| Avadel CNS Pharmaceuticals | Meals · 2025-03-27 | Lumryz | $25 |
| Inspire Medical Systems | Meals · 2025-03-17 | Inspire | $22 |
| Inspire Medical Systems | Meals · 2025-03-10 | Inspire | $14 |
| Jazz Pharmaceuticals | Meals · 2025-03-04 | Xywav | $85 |
| Inspire Medical Systems | Meals · 2025-02-27 | Inspire | $132 |
| Jazz Pharmaceuticals | Meals · 2025-02-21 | Xywav | $7 |
| Jazz Pharmaceuticals | Meals · 2025-02-21 | Xywav | $6 |
| Jazz Pharmaceuticals | Meals · 2025-02-21 | Xywav | $2 |
| Avadel CNS Pharmaceuticals | Meals · 2025-02-19 | Lumryz | $34 |
| Avadel CNS Pharmaceuticals | Meals · 2025-02-06 | Lumryz | $125 |
| Jazz Pharmaceuticals | Meals · 2025-02-05 | Xywav | $58 |
| Avadel CNS Pharmaceuticals | Meals · 2025-01-21 | Lumryz | $6 |
| Jazz Pharmaceuticals | Meals · 2025-01-10 | Xywav | $18 |
| Jazz Pharmaceuticals | Meals · 2025-01-10 | Xywav | $7 |
| Fisher & Paykel Healthcare | Meals · 2025-01-10 | Fisher & Paykel Healthcare | $27 |
| Jazz Pharmaceuticals | Consulting · 2025-01-08 | Xywav | $150 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $834
| Jazz Pharmaceuticals | Xywav | $560 | 17 payments
|
| Inspire Medical Systems | Inspire | $166 | 8 payments
|
| Abbvie | Ubrelvy | $52 | 2 payments
|
| Ucb | Briviact | $33 | 2 payments
|
| Avadel CNS Pharmaceuticals | Lumryz | $23 | 1 payment
|
2023: $752
| Jazz Pharmaceuticals | Xywav | $368 | 14 payments
|
| Inspire Medical Systems | Inspire | $318 | 14 payments
|
| Axsome Therapeutics | Sunosi | $51 | 3 payments
|
| Resmed | Airsense | $15 | 1 payment
|
2022: $58
| Harmony Biosciences | Wakix | $23 | 1 payment
|
| Jazz Pharmaceuticals | Xywav | $22 | 1 payment
|
| Philips Electronics North America | (8946) Ds2 A Cell Core | $13 | 1 payment
|
2021: $111
| Harmony Biosciences | Wakix | $48 | 1 payment
|
| Jazz Pharmaceuticals | Xywav | $38 | 2 payments
|
| Resmed | Airsense | $25 | 1 payment
|
2020: $37
| Jazz Pharmaceuticals | Xyrem | $19 | 1 payment
|
| Harmony Biosciences | Wakix | $18 | 1 payment
|
2019: $93
| Jazz Pharmaceuticals | Xyrem | $66 | 4 payments
|
| Arbor Pharmaceuticals | Horizant | $27 | 2 payments
|
Professional record
- NPI
- 1427347673
- Licence
- CA A124102, MO 2019005180California A124102: Current · expires 2027-01-31
- Group
- Southern California Permanente Medical Group · Stanford Health Care
- Gender
- Female
More record details
- Sole proprietor
- Yes
- Taxonomy
- Federal specialty code 2084S0012X (2084S0012X); Federal specialty code 207RS0012X (207RS0012X)
- Mailing address
- 411 N Lakeview Ave, Anaheim, CA, 92807
- NPI first listed
- 2011-03-28
- NPI last updated
- 2025-07-16
- NPI record certified
- 2025-07-16
This is when the NPI record was last certified, not a medical board exam.
This office lists an electronic records connection.